Cytotoxic withanolides from Physalis angulata var. villosa and the apoptosis-inducing effect via ROS generation and the activation of MAPK in human osteosarcoma cells. Issue 58 (31st May 2016)
- Record Type:
- Journal Article
- Title:
- Cytotoxic withanolides from Physalis angulata var. villosa and the apoptosis-inducing effect via ROS generation and the activation of MAPK in human osteosarcoma cells. Issue 58 (31st May 2016)
- Main Title:
- Cytotoxic withanolides from Physalis angulata var. villosa and the apoptosis-inducing effect via ROS generation and the activation of MAPK in human osteosarcoma cells
- Authors:
- Ma, Ting
Zhang, Wen-Na
Yang, Lei
Zhang, Chao
Lin, Ru
Shan, Si-Ming
Zhu, Meng-Di
Luo, Jian-Guang
Kong, Ling-Yi - Abstract:
- Abstract : Physagulide I induced apoptosis and cell cycle arrest via ROS generation and the activation of MAPK in human osteosarcoma cells. Abstract : Withanolides are a large group of steroidal lactones found in Solanaceae plants that exhibit potential anticancer activities. In the present study, eight new withanolides, physagulides A–H (1–8 ), along with ten known analogues (9–18 ), were isolated and identified from the whole plants of Physalis angulata var. villosa . All compounds were evaluated for their cytotoxicity against three human cancer cell lines, human hepatoma (HepG2), human breast carcinoma (MCF-7) and human osteosarcoma (MG-63) cells. Compounds9, 10, 14, 17 and18 exhibited cytotoxicity on all cell lines with half maximal inhibitory concentration (IC50 ) values of 0.06–6.73 μM, comparable to those of the reference agent cisplatin. One of the potent compounds, physagulide I (9 ) arrested cells in the G2 /M phase and activated caspase-dependent apoptotic pathways. Furthermore, apoptosis induced by physagulide I in MG-63 cells was associated with the generation of reactive oxygen species (ROS) and the activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinases (JNK). These results suggest that physagulide I may be a promising agent for the treatment of cancer.
- Is Part Of:
- RSC advances. Volume 6:Issue 58(2016)
- Journal:
- RSC advances
- Issue:
- Volume 6:Issue 58(2016)
- Issue Display:
- Volume 6, Issue 58 (2016)
- Year:
- 2016
- Volume:
- 6
- Issue:
- 58
- Issue Sort Value:
- 2016-0006-0058-0000
- Page Start:
- 53089
- Page End:
- 53100
- Publication Date:
- 2016-05-31
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/RA ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c6ra08574a ↗
- Languages:
- English
- ISSNs:
- 2046-2069
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.750300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2461.xml